Biomed Central Ltd

SHERPA: Unknown

People

  1. D'Angelo
    D'Angelo
  2. Tap
    Tap
  3. Kelly
    Kelly
  4. Chi
    Chi
  5. Antonescu
    Antonescu
  6. Gounder
    Gounder
  7. Richards
    Richards
  8. Avutu
    Avutu
  9. Barker
    Barker
  10. Bradic
    Bradic

Groups

  1. Department of Medicine (32)
  2. Sarcoma Service (32)
  3. Solid Tumor Oncology Division (32)
  4. Hematologic Malignancies, Division of (24)
  5. GSK Faculty (5)
  6. Tow Center for Developmental Oncology (TCDO) (5)
  7. Human Oncology and Pathogenesis Program (4)
  8. Department of Pathology and Laboratory Medicine (2)
  9. Melanoma Disease Management Team (2)
  10. Weinberg Fellows (2)
Search Within
  1. "Sarcoma Service"
Formats
  1. Journal Article (15)
  2. Meeting Abstract (14)
  3. Guidelines (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Department of Medicine (32)
  2. Sarcoma Service (32)
  3. Solid Tumor Oncology Division (32)
  4. Hematologic Malignancies, Division of (24)
  5. GSK Faculty (5)
  6. Tow Center for Developmental Oncology (TCDO) (5)

More Groups

People
  1. Sandra D'Angelo (24)
  2. William Tap (6)
  3. Ciara Kelly (5)
  4. Ping Chi (4)
  5. Allison Richards (2)
  6. Cristina Antonescu (2)

More People

Years
  1. 2024 (3)
  2. 2022 (6)
  3. 2021 (4)
  4. 2020 (7)
  5. 2019 (5)
  6. 2018 (4)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (25)
  2. Journal of Hematology & Oncology (3)
  3. BMC Cancer (2)
  4. Cardio-Oncology (1)
  5. Journal of Experimental & Clinical Cancer Research (1)

Results (32)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): Expansion cohorts and correlative analyses
    Journal Article

    Seligson, N. D.; Chen, J. L.; Goodrich, A. C.; Van Tine, B. A.; Campbell, J. D.; Richards, A. L.; Antonescu, C. R.; Liebner, D. A.; Milhem, M. M.; Streicher, H.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Expect the unexpected: Fulminant myocardial cytotoxic injury from Trabectedin
    Journal Article

    Tsay, A. J.; Satish, M.; Corley, E.; Ezema, A.; DeJesus, N.; Wisely, S.; McAleer, E.; Zhang, C.; Yuan, S.; Homan, E.; more...
    Cardio-Oncology (2024)

    Fulltext@MSK | Save
  • Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): From premalignant to metastatic disease
    Guidelines

    Luke, J. J.; Davar, D.; Andtbacka, R. H.; Bhardwaj, N.; Brody, J. D.; Chesney, J.; Coffin, R.; de Baere, T.; de Gruijl, T. D.; Fury, M.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from the JAVELIN Merkel 200 trial
    Meeting Abstract

    D'Angelo, S.; Lebbé, C.; Mortier, L.; Brohl, A.; Fazio, N.; Grob, J. J.; Prinzi, N.; Hanna, G.; Hassel, J.; Kiecker, F.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Post-hoc analysis from two phase I/II NY-ESO-1-TCR T-cell therapy clinical trials in patients with advanced sarcoma (SS or MRCLS) demonstrates response across a range of NY-ESO-1 expression
    Meeting Abstract

    Klohe, E.; Suchindran, S.; Kapoor, G.; D'Souza, J.; Corigleano, E.; Araujo, D.; D'Angelo, S.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Biomarker correlates of letetresgene autoleucel (lete-cel; GSK3377794) response in patients with advanced myxoid/round cell liposarcoma (MRCLS)
    Meeting Abstract

    Kapoor, G.; Zajic, S.; Suchindran, S.; Kim, J.; Saxena, U.; Bhaskar, A.; Kaczynski, H.; Nathenson, M.; D'Souza, J.; Rich, B.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: Analysis from the phase 3 INVICTUS trial
    Journal Article

    Schöffski, P.; George, S.; Heinrich, M. C.; Zalcberg, J. R.; Bauer, S.; Gelderblom, H.; Serrano, C.; Jones, R. L.; Attia, S.; D’Amato, G.; more...
    BMC Cancer (2022)

    Fulltext@MSK | Save
  • Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center
    Journal Article

    Rosenbaum, E.; Antonescu, C. R.; Smith, S.; Bradic, M.; Kashani, D.; Richards, A. L.; Donoghue, M.; Kelly, C. M.; Nacev, B.; Chan, J. E.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival
    Journal Article

    Manitz, J.; D'Angelo, S. P.; Apolo, A. B.; Eggleton, S. P.; Bajars, M.; Bohnsack, O.; Gulley, J. L.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Biomarker correlates of response in patients with advanced myxoid/round cell liposarcoma (MRCLS) treated with NY-ESO-1 TCR T Cells (letetresgene autoleucel)
    Meeting Abstract

    Kapoor, G.; Zajic, S.; Suchindran, S.; Kim, J.; Eleftheriadou, I.; Huff, A.; Nathenson, M.; Druta, M.; Van Tine, B.; Somaiah, N.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save